AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 165 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $321,000 | +24.9% | 34,100 | +1.4% | 0.00% | – |
| Q2 2020 | $257,000 | -45.0% | 33,623 | -55.5% | 0.00% | – |
| Q1 2020 | $467,000 | -52.0% | 75,640 | -5.4% | 0.00% | -100.0% |
| Q4 2019 | $973,000 | +146.3% | 79,988 | +133.6% | 0.00% | – |
| Q3 2019 | $395,000 | +22.3% | 34,247 | +5.5% | 0.00% | – |
| Q2 2019 | $323,000 | -23.3% | 32,449 | -0.7% | 0.00% | – |
| Q1 2019 | $421,000 | -26.1% | 32,682 | -13.0% | 0.00% | -100.0% |
| Q4 2018 | $570,000 | -32.9% | 37,567 | -11.5% | 0.00% | 0.0% |
| Q3 2018 | $849,000 | +13.4% | 42,448 | +10.5% | 0.00% | 0.0% |
| Q2 2018 | $749,000 | -13.0% | 38,419 | -10.0% | 0.00% | 0.0% |
| Q1 2018 | $861,000 | +53.2% | 42,710 | +0.6% | 0.00% | 0.0% |
| Q4 2017 | $562,000 | -40.0% | 42,442 | -16.4% | 0.00% | 0.0% |
| Q3 2017 | $936,000 | -26.8% | 50,748 | -26.9% | 0.00% | 0.0% |
| Q2 2017 | $1,279,000 | -61.0% | 69,465 | -52.2% | 0.00% | -66.7% |
| Q1 2017 | $3,280,000 | +44.0% | 145,442 | +122.3% | 0.00% | +50.0% |
| Q4 2016 | $2,277,000 | +92.6% | 65,431 | +35.5% | 0.00% | +100.0% |
| Q3 2016 | $1,182,000 | +18.8% | 48,292 | +16.1% | 0.00% | 0.0% |
| Q2 2016 | $995,000 | -10.4% | 41,611 | -12.3% | 0.00% | 0.0% |
| Q1 2016 | $1,110,000 | +72.9% | 47,457 | +123.2% | 0.00% | 0.0% |
| Q4 2015 | $642,000 | -79.0% | 21,262 | -72.4% | 0.00% | -75.0% |
| Q3 2015 | $3,058,000 | -59.4% | 76,975 | -29.4% | 0.00% | -42.9% |
| Q2 2015 | $7,526,000 | +135.9% | 108,970 | +86.7% | 0.01% | +133.3% |
| Q1 2015 | $3,191,000 | +54.2% | 58,380 | +20.2% | 0.00% | +50.0% |
| Q4 2014 | $2,070,000 | +141.0% | 48,582 | +80.5% | 0.00% | +100.0% |
| Q3 2014 | $859,000 | +81.2% | 26,913 | +17.7% | 0.00% | – |
| Q2 2014 | $474,000 | -47.0% | 22,861 | -50.6% | 0.00% | -100.0% |
| Q1 2014 | $895,000 | -52.5% | 46,255 | -40.5% | 0.00% | -50.0% |
| Q4 2013 | $1,886,000 | +97.9% | 77,700 | +75.0% | 0.00% | +100.0% |
| Q3 2013 | $953,000 | +70.2% | 44,389 | +76.5% | 0.00% | 0.0% |
| Q2 2013 | $560,000 | +9.4% | 25,156 | +17.3% | 0.00% | 0.0% |
| Q1 2013 | $512,000 | – | 21,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,390,000 | $33,584,000 | 1.92% |
| Bleichroeder LP | 1,299,994 | $9,945,000 | 1.76% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $31,518,000 | 1.38% |
| Palo Alto Investors LP | 2,959,587 | $22,641,000 | 1.36% |
| Permanens Capital L.P. | 359,461 | $2,750,000 | 1.04% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,607 | $242,000 | 0.19% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $2,662,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 795,611 | $6,086,000 | 0.07% |
| Teza Capital Management LLC | 23,269 | $178,000 | 0.04% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $297,000 | 0.03% |